Get the Stockscreener App
6.48
8.09%
-0.57
After Hours:
6.48
Inogen Inc stock is currently priced at $6.48, with a 24-hour trading volume of 193.28K.
It has seen a -8.09% decreased in the last 24 hours and a -13.83% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $6.95 pivot point. If it approaches the $6.47 support level, significant changes may occur.
Previous Close:
$7.05
Open:
$6.99
24h Volume:
193.28K
Market Cap:
$156.70M
Revenue:
$315.66M
Net Income/Loss:
$-102.45M
P/E Ratio:
-1.5465
EPS:
-4.19
Net Cash Flow:
$-30.25M
1W Performance:
-8.60%
1M Performance:
-13.83%
6M Performance:
+43.36%
1Y Performance:
-50.95%
1D Range:
$6.42
$6.99
52W Range:
$4.13
$14.10
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
326 Bollay Drive, Goleta, CA
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue?
Zacks Investment Research
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
Zacks Investment Research
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
Benzinga
Inogen (INGN) Q4 Earnings Miss Estimates, Gross Margin Improves
Zacks Investment Research
Inogen Inc Stock (INGN) Financials Data
Inogen Inc (INGN) Revenue 2024
INGN reported a revenue (TTM) of $315.66 million for the quarter ending December 31, 2023, a -16.32% decline year-over-year.
Inogen Inc (INGN) Net Income 2024
INGN net income (TTM) was -$102.45 million for the quarter ending December 31, 2023, a -22.30% decrease year-over-year.
Inogen Inc (INGN) Cash Flow 2024
INGN recorded a free cash flow (TTM) of -$30.25 million for the quarter ending December 31, 2023, a +48.52% increase year-over-year.
Inogen Inc (INGN) Earnings per Share 2024
INGN earnings per share (TTM) was -$4.41 for the quarter ending December 31, 2023, a -20.49% decline year-over-year.
Inogen Inc Stock (INGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Somer Jason | EVP, Gen. Counsel & Secretary |
Mar 01 '24 |
Option Exercise |
0.00 |
7,150 |
0 |
11,064 |
| Somer Jason | EVP, Gen. Counsel & Secretary |
Dec 01 '23 |
Option Exercise |
0.00 |
576 |
0 |
4,200 |
| Glezer Stanislav | EVP, Chief Technology Officer |
Dec 01 '23 |
Option Exercise |
0.00 |
4,555 |
0 |
12,146 |
| Somer Jason | EVP, Gen. Counsel & Secretary |
Sep 01 '23 |
Option Exercise |
0.00 |
577 |
0 |
3,911 |
| Shabshab Nabil | CEO and President |
Sep 01 '23 |
Option Exercise |
0.00 |
3,686 |
0 |
38,933 |
| Glezer Stanislav | EVP, Chief Technology Officer |
Sep 01 '23 |
Option Exercise |
0.00 |
769 |
0 |
7,985 |
| Shabshab Nabil | CEO and President |
Jun 01 '23 |
Option Exercise |
0.00 |
3,685 |
0 |
37,188 |
| Glezer Stanislav | EVP, Chief Technology Officer |
Jun 01 '23 |
Option Exercise |
0.00 |
768 |
0 |
7,609 |
| Somer Jason | EVP, Gen. Counsel & Secretary |
Jun 01 '23 |
Option Exercise |
0.00 |
576 |
0 |
3,620 |
| Parr George J | Chief Commercial Officer |
Jun 01 '23 |
Option Exercise |
0.00 |
1,126 |
0 |
8,674 |
About Inogen Inc
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.
1.19%
0.10%
Cap:
|
Volume (24h):